KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Globus Medical (GMED) EBT (2016 - 2026)

Globus Medical filings provide 15 years of EBT readings, the most recent being $169.2 million for Q4 2025.

  • On a quarterly basis, EBT rose 586.07% to $169.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $605.1 million, a 401.41% increase, with the full-year FY2025 number at $605.1 million, up 401.21% from a year prior.
  • EBT hit $169.2 million in Q4 2025 for Globus Medical, up from $144.0 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $188.2 million in Q2 2025 to a low of -$8.6 million in Q1 2024.
  • Median EBT over the past 5 years was $57.1 million (2021), compared with a mean of $66.2 million.
  • The widest YoY moves for EBT: up 2149.78% in 2024, down 113.61% in 2024.
  • Globus Medical's EBT stood at $24.2 million in 2021, then skyrocketed by 173.75% to $66.4 million in 2022, then crashed by 62.33% to $25.0 million in 2023, then fell by 1.31% to $24.7 million in 2024, then surged by 586.07% to $169.2 million in 2025.
  • The last three reported values for EBT were $169.2 million (Q4 2025), $144.0 million (Q3 2025), and $188.2 million (Q2 2025) per Business Quant data.